Marrone Bio Innovations Appoints Matthew O. Brecht, Ph.D. as New Cannabis Key Account Manager
January 08 2019 - 8:31AM
Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading
global provider of bio-based pest management and plant health
products, today announced that Matthew O. Brecht, Ph.D. has joined
as Key Account Manager for the cannabis agricultural market
segment.
In this role, Dr. Brecht, will oversee MBI’s key
customer accounts in cannabis and help grow MBI sales within this
rapidly growing market. The role will focus on managing a team
dedicated to understanding customer needs and the fit of MBI’s
biological suite of products, including Regalia® CG biofungicide,
Grandevo® CG and Venerate® CG bioinsecticides, Stargus®
biofungicide, Majestene® bionematicide, and Haven® Crop Protectant.
In addition, Dr. Brecht will play an integral role in the broader
cannabis community by helping to educate, train and inform our
retailer-distributors and their growers on the advantages of
biological solutions.
According to the November 2019 ASD Cannabis
Market – Global Forecast to 2023 Report, the cannabis market is
expected to grow from $10.3 billion in 2018 to $39.4 billion by
2023, at a compound annual growth rate of 30.7% during the forecast
period. The major factors driving the cannabis market include the
growth of medicinal applications of cannabis and the increased
legalization of cannabis throughout the world.
Dr. Brecht is widely renowned as a thought
leader in the cannabis industry, bringing over 20 years of
experience in farming systems, plant pathology, crop protection,
testing, epidemiology, crop management and pest control strategies
in agricultural production. Most recently, Dr. Brecht was the
President and Founder of Dutch Valley Farms, an indoor cannabis
producer located in Portland, OR. Prior to founding Dutch Valley
Farms, he spent over 11 years as Territory Manager at Syngenta,
growing one of the Company’s largest U.S. sales regions. Dr. Brecht
has a Ph.D. & M.S. in Plant Pathology from the University of
Florida, Gainesville and a B.S. in Biology from University of North
Carolina, Wilmington, NC.
“Dr. Brecht is a well-known thought leader in
the cannabis community, seen as a trusted advisor and lead
agronomist on the advancement of cannabis as an important crop in
domestic agriculture,” said Barner Jones, Director of National
Sales and Account Management at MBI. “As we continue to see
heightened interest in cannabis growing from traditional
agricultural growers, it is increasingly important to have
resources for farmers and their retailer-distributors on common
growing practices and biological solutions to help with pest &
disease pressures such as mite control, powdery mildew and
Botrytis. I look forward to growing our cannabis segment in
conjunction with Dr. Brecht and our cannabis team.”
“I am pleased to have joined MBI, an undisputed
leader within the biological crop protection market,” said Dr.
Brecht. “As a former cannabis farm operator, I have a deep
understanding of the need for MBI’s products, which are unmatched
in solving common issues facing cannabis growers today. I see
cannabis as a segment with significant growth potential for both
MBI and the broader agricultural community as a whole and look
forward to working closely with the MBI team to support this growth
while helping the cannabis community grow towards a more
sustainable future.”
About Marrone Bio Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII)
strives to lead the movement to more a sustainable world through
the discovery, development and sale of innovative biological
products for crop protection, plant health and waterway systems
treatment that support a better tomorrow for farmers, turf managers
and consumers around the globe. MBI has screened over 18,000
microorganisms and 350 plant extracts, leveraging its in-depth
knowledge of plant and soil microbiomes enhanced by advanced
molecular technologies to rapidly develop seven effective and
environmentally responsible pest management products to help
customers operate more sustainably while uniquely improving plant
health and increasing crop yields. Supported by a robust portfolio
of over 400 issued and pending patents around its superior natural
product chemistry, MBI’s currently available commercial products
are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven®
and Amplitude™, Zelto® and Zequanox®.
Learn more about Marrone Bio Innovations at:
marronebio.comFollow us on Social
Media:twitter.com/marronebio linkedin.com/company/marrone-bio/ instagram.com/marronebio/
Marrone Bio Innovations Forward Looking
StatementsThis press release contains forward-looking
statements that involve substantial risks and uncertainties. All
statements, other than statements of historical facts, included in
this press release regarding strategy, future operations and plans,
including assumptions underlying such statements, are
forward-looking statements, and should not be relied upon as
representing MBI’s views as of any subsequent date. Examples of
such statements include the potential of the MBI’s products and
market projections in cannabis. Such forward-looking statements are
based on information available to the Company as of the date of
this release and involve a number of risks and uncertainties, some
beyond the Company’s control, that could cause actual results to
differ materially from those anticipated by these forward-looking
statements, including weather, regulatory and other factors
affecting demand for the MBI’s products, any difficulty in
marketing MBI’s products in its target markets, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Marrone Bio Innovations Contacts: Barner
JonesDirector of National Sales and Account ManagementMain:
530-750-2800Email: bjones@marronebio.com
MBI Investor Relations: Greg Falesnik Managing
Director MZ Group – MZ North America Main: 949-385-6449
MBII@mzgroup.us www.mzgroup.us
Commercial Agriculture & Turf Public
Relations:Alicia GillmanDirector, Global
CommunicationsMarrone Bio Innovations Main: 480-889-4219Email:
agillman@marronebio.com
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marrone Bio Innovations (NASDAQ:MBII)
Historical Stock Chart
From Sep 2023 to Sep 2024